MATHIS LARRY
Insider CIK 1283700 · HTA Director · ALXN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2019-07-09 | 2019-07-09 | 3,583 | $27.91 | $100.0K | 60,450 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2018-07-09 | 2018-07-09 | 3,655 | $27.36 | $100.0K | 56,867 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2017-07-12 | 2017-07-14 | 3,389 | $29.51 | $100.0K | 53,212 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2016-07-07 | 2016-07-08 | 3,061 | — | $0 | 49,823 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2015-07-08 | 2015-07-10 | 4,000 | — | $0 | 46,762 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2014-10-15 | 2014-10-17 | 2,500 | — | $0 | 85,524 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2014-07-09 | 2014-07-11 | 7,500 | — | $0 | 83,024 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 895 | — | $0 | 30,351 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-03 | 2014-02-05 | 3,237 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-03 | 2014-02-05 | 1,712 | — | $0 | 1,713 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-03 | 2014-02-05 | 5,572 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-03 | 2014-02-05 | 7,932 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-03 | 2014-02-05 | 12,276 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-03 | 2014-02-05 | 20,000 | — | $0 | 10,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-03 | 2014-02-05 | 30,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-03 | 2014-02-05 | 20,000 | $10.84 | $216.8K | 110,185 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-03 | 2014-02-05 | 30,000 | $18.01 | $540.3K | 90,185 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-03 | 2014-02-05 | 12,276 | $16.83 | $206.6K | 60,185 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-03 | 2014-02-05 | 7,932 | $26.64 | $211.3K | 47,909 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-03 | 2014-02-05 | 5,572 | $49.43 | $275.4K | 39,977 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 15,020 | $155.23 | $2.33M | 95,165 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 9,664 | $156.24 | $1.51M | 85,501 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 12,322 | $157.35 | $1.94M | 73,179 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 30,222 | $158.41 | $4.79M | 42,957 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 13,501 | $159.01 | $2.15M | 29,456 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-03 | 2014-02-05 | 3,237 | $88.40 | $286.2K | 34,405 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-03 | 2014-02-05 | 1,712 | $96.35 | $165.0K | 31,168 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2013-07-09 | 2013-07-11 | 7,500 | — | $0 | 75,524 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2013-05-07 | 2013-05-09 | 3,425 | — | $0 | 3,425 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-04-29 | 2013-05-01 | 3,115 | $99.03 | $308.5K | 29,456 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-02-06 | 2013-02-08 | 2,471 | — | $0 | 32,571 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | P Buy | 2012-12-07 | 2012-12-07 | 15,000 | $9.99 | $149.8K | 68,024 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | P Buy | 2012-12-06 | 2012-12-07 | 10,000 | $10.07 | $100.7K | 53,024 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award | 2012-07-09 | 2012-07-11 | 7,500 | — | $0 | 43,025 | SEC↗ |
| HTA HEALTHCARE TRUST OF AMERIC | A Award deriv | 2012-06-06 | 2012-06-08 | 135,000 | — | $0 | 135,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-29 | 2012-05-31 | 18,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale deriv | 2012-05-29 | 2012-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-29 | 2012-05-31 | 18,000 | $5.55 | $99.9K | 29,115 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-05-29 | 2012-05-31 | 18,985 | $92.29 | $1.75M | 11,115 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-05-29 | 2012-05-31 | 14,015 | $91.76 | $1.29M | 30,100 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-29 | 2012-05-31 | 15,000 | $8.18 | $122.7K | 44,115 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2012-05-08 | 2012-05-09 | 3,237 | — | $0 | 3,237 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-17 | 2012-02-21 | 24,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-17 | 2012-02-21 | 5,450 | $81.23 | $442.7K | 11,115 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-17 | 2012-02-21 | 24,000 | $81.23 | $1.95M | 16,565 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-17 | 2012-02-21 | 24,000 | $5.73 | $137.5K | 40,565 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-03 | 2012-02-06 | 3,115 | — | $0 | 16,565 | SEC↗ |